Modulation of visceral fat by estrogens after menopause

Trial Profile

Modulation of visceral fat by estrogens after menopause

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Oct 2013

At a glance

  • Drugs Conjugated estrogens (Primary) ; Medroxyprogesterone (Primary) ; Raloxifene (Primary)
  • Indications Menopausal syndrome
  • Focus Pharmacodynamics
  • Acronyms AFTER
  • Most Recent Events

    • 15 Nov 2006 Status change
    • 30 Oct 2006 New trial record.
    • 01 Feb 2006 Primary endpoint 'Mass-of-body-fat' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top